Hotline: +86-18022463983    020-85206863

Global Embolism Protector Market Research Report 2025

Published Date: 2025-12-04   |   Pages: 101   |   Tables: 101   |  Medical Devices & Consumables

The global market for Embolism Protector was valued at US$ 310 million in the year 2024 and is projected to reach a revised size of US$ 433 million by 2031, growing at a CAGR of 4.6% during the forecast period.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Embolism Protector competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Embolization protectors are used in cardiovascular or peripheral interventional procedures to capture embolic debris and prevent it from entering critical blood vessels, thereby reducing the risk of stroke and vascular occlusion. The industry chain includes upstream components such as nickel-titanium alloy filters, polyurethane, stainless steel wire, microfiltration membranes, and catheter assemblies; midstream components encompass device design, catheter extrusion, coating, and precision assembly; and downstream components include hospitals, cardiovascular centers, interventional departments, and distributors, as well as sterilization, regulatory certification, and clinical training support. In 2024, the global production of embolization protectors was approximately 223,400 units, with a global average market price of approximately US$1,388 each. The gross profit margin of major companies in the industry ranges from 45% to 60%. Single-line production capacity is 4,000 to 6,000 units per year.
North American market for Embolism Protector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Embolism Protector is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Embolism Protector include Int Medical, Microport, Skynor Medical, Venus Medtech (Hangzhou) Inc., Medtronic, LEPU MEDICAL, Cordis, Filterlex, invamed, Shanghai HeartCare Medical Technology Corporation Limited, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolism Protector, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolism Protector.
The Embolism Protector market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Embolism Protector market comprehensively. Regional market sizes, concerning products by Type, by Application, by Protection Mechanism and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolism Protector manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Protection Mechanism and by regions.
By Company
Int Medical
Microport
Skynor Medical
Venus Medtech (Hangzhou) Inc.
Medtronic
LEPU MEDICAL
Cordis
Filterlex
invamed
Shanghai HeartCare Medical Technology Corporation Limited
Boston Scientific
Parite Medikal
Abbott
DUKE Empirical
Emblok
Transverse Medical
Segment by Type
Carotid Embolism Protection Device
Peripheral Vascular Embolism Protector
Coronary Embolism Protector
Segment by Protection Mechanism
Filter-Type Embolism Protector
Balloon-Occlusion Embolism Protector
Flow-Reversal Embolism Protector
Segment by Application
Cardiovascular Intervention Centers
General Hospitals
Specialized Vascular Clinics
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Embolism Protector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Embolism Protector in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Embolism Protector Market Overview
1.1 Product Definition
1.2 Embolism Protector by Type
1.2.1 Global Embolism Protector Market Value Comparison by Type (2024 VS 2031)
1.2.2 Carotid Embolism Protection Device
1.2.3 Peripheral Vascular Embolism Protector
1.2.4 Coronary Embolism Protector
1.3 Embolism Protector by Protection Mechanism
1.3.1 Global Embolism Protector Market Value Comparison by Protection Mechanism: 2024 VS 2031
1.3.2 Filter-Type Embolism Protector
1.3.3 Balloon-Occlusion Embolism Protector
1.3.4 Flow-Reversal Embolism Protector
1.4 Embolism Protector by Application
1.4.1 Global Embolism Protector Market Value by Application (2024 VS 2031)
1.4.2 Cardiovascular Intervention Centers
1.4.3 General Hospitals
1.4.4 Specialized Vascular Clinics
1.5 Global Embolism Protector Market Size Estimates and Forecasts
1.5.1 Global Embolism Protector Revenue 2020-2031
1.5.2 Global Embolism Protector Sales 2020-2031
1.5.3 Global Embolism Protector Market Average Price (2020-2031)
1.6 Assumptions and Limitations
2 Embolism Protector Market Competition by Manufacturers
2.1 Global Embolism Protector Sales Market Share by Manufacturers (2020-2025)
2.2 Global Embolism Protector Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Embolism Protector Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Embolism Protector, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Embolism Protector, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Embolism Protector, Product Type & Application
2.7 Global Key Manufacturers of Embolism Protector, Date of Enter into This Industry
2.8 Global Embolism Protector Market Competitive Situation and Trends
2.8.1 Global Embolism Protector Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Embolism Protector Players Market Share by Revenue
2.8.3 Global Embolism Protector Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Embolism Protector Market Scenario by Region
3.1 Global Embolism Protector Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Embolism Protector Sales by Region: 2020-2031
3.2.1 Global Embolism Protector Sales by Region: 2020-2025
3.2.2 Global Embolism Protector Sales by Region: 2026-2031
3.3 Global Embolism Protector Revenue by Region: 2020-2031
3.3.1 Global Embolism Protector Revenue by Region: 2020-2025
3.3.2 Global Embolism Protector Revenue by Region: 2026-2031
3.4 North America Embolism Protector Market Facts & Figures by Country
3.4.1 North America Embolism Protector Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Embolism Protector Sales by Country (2020-2031)
3.4.3 North America Embolism Protector Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Embolism Protector Market Facts & Figures by Country
3.5.1 Europe Embolism Protector Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Embolism Protector Sales by Country (2020-2031)
3.5.3 Europe Embolism Protector Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Embolism Protector Market Facts & Figures by Region
3.6.1 Asia Pacific Embolism Protector Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Embolism Protector Sales by Region (2020-2031)
3.6.3 Asia Pacific Embolism Protector Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Embolism Protector Market Facts & Figures by Country
3.7.1 Latin America Embolism Protector Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Embolism Protector Sales by Country (2020-2031)
3.7.3 Latin America Embolism Protector Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Embolism Protector Market Facts & Figures by Country
3.8.1 Middle East and Africa Embolism Protector Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Embolism Protector Sales by Country (2020-2031)
3.8.3 Middle East and Africa Embolism Protector Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Embolism Protector Sales by Type (2020-2031)
4.1.1 Global Embolism Protector Sales by Type (2020-2025)
4.1.2 Global Embolism Protector Sales by Type (2026-2031)
4.1.3 Global Embolism Protector Sales Market Share by Type (2020-2031)
4.2 Global Embolism Protector Revenue by Type (2020-2031)
4.2.1 Global Embolism Protector Revenue by Type (2020-2025)
4.2.2 Global Embolism Protector Revenue by Type (2026-2031)
4.2.3 Global Embolism Protector Revenue Market Share by Type (2020-2031)
4.3 Global Embolism Protector Price by Type (2020-2031)
5 Segment by Application
5.1 Global Embolism Protector Sales by Application (2020-2031)
5.1.1 Global Embolism Protector Sales by Application (2020-2025)
5.1.2 Global Embolism Protector Sales by Application (2026-2031)
5.1.3 Global Embolism Protector Sales Market Share by Application (2020-2031)
5.2 Global Embolism Protector Revenue by Application (2020-2031)
5.2.1 Global Embolism Protector Revenue by Application (2020-2025)
5.2.2 Global Embolism Protector Revenue by Application (2026-2031)
5.2.3 Global Embolism Protector Revenue Market Share by Application (2020-2031)
5.3 Global Embolism Protector Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Int Medical
6.1.1 Int Medical Company Information
6.1.2 Int Medical Description and Business Overview
6.1.3 Int Medical Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Int Medical Embolism Protector Product Portfolio
6.1.5 Int Medical Recent Developments/Updates
6.2 Microport
6.2.1 Microport Company Information
6.2.2 Microport Description and Business Overview
6.2.3 Microport Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Microport Embolism Protector Product Portfolio
6.2.5 Microport Recent Developments/Updates
6.3 Skynor Medical
6.3.1 Skynor Medical Company Information
6.3.2 Skynor Medical Description and Business Overview
6.3.3 Skynor Medical Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Skynor Medical Embolism Protector Product Portfolio
6.3.5 Skynor Medical Recent Developments/Updates
6.4 Venus Medtech (Hangzhou) Inc.
6.4.1 Venus Medtech (Hangzhou) Inc. Company Information
6.4.2 Venus Medtech (Hangzhou) Inc. Description and Business Overview
6.4.3 Venus Medtech (Hangzhou) Inc. Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Venus Medtech (Hangzhou) Inc. Embolism Protector Product Portfolio
6.4.5 Venus Medtech (Hangzhou) Inc. Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Embolism Protector Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 LEPU MEDICAL
6.6.1 LEPU MEDICAL Company Information
6.6.2 LEPU MEDICAL Description and Business Overview
6.6.3 LEPU MEDICAL Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.6.4 LEPU MEDICAL Embolism Protector Product Portfolio
6.6.5 LEPU MEDICAL Recent Developments/Updates
6.7 Cordis
6.7.1 Cordis Company Information
6.7.2 Cordis Description and Business Overview
6.7.3 Cordis Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Cordis Embolism Protector Product Portfolio
6.7.5 Cordis Recent Developments/Updates
6.8 Filterlex
6.8.1 Filterlex Company Information
6.8.2 Filterlex Description and Business Overview
6.8.3 Filterlex Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Filterlex Embolism Protector Product Portfolio
6.8.5 Filterlex Recent Developments/Updates
6.9 invamed
6.9.1 invamed Company Information
6.9.2 invamed Description and Business Overview
6.9.3 invamed Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.9.4 invamed Embolism Protector Product Portfolio
6.9.5 invamed Recent Developments/Updates
6.10 Shanghai HeartCare Medical Technology Corporation Limited
6.10.1 Shanghai HeartCare Medical Technology Corporation Limited Company Information
6.10.2 Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
6.10.3 Shanghai HeartCare Medical Technology Corporation Limited Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Shanghai HeartCare Medical Technology Corporation Limited Embolism Protector Product Portfolio
6.10.5 Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
6.11 Boston Scientific
6.11.1 Boston Scientific Company Information
6.11.2 Boston Scientific Description and Business Overview
6.11.3 Boston Scientific Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Boston Scientific Embolism Protector Product Portfolio
6.11.5 Boston Scientific Recent Developments/Updates
6.12 Parite Medikal
6.12.1 Parite Medikal Company Information
6.12.2 Parite Medikal Description and Business Overview
6.12.3 Parite Medikal Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Parite Medikal Embolism Protector Product Portfolio
6.12.5 Parite Medikal Recent Developments/Updates
6.13 Abbott
6.13.1 Abbott Company Information
6.13.2 Abbott Description and Business Overview
6.13.3 Abbott Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Abbott Embolism Protector Product Portfolio
6.13.5 Abbott Recent Developments/Updates
6.14 DUKE Empirical
6.14.1 DUKE Empirical Company Information
6.14.2 DUKE Empirical Description and Business Overview
6.14.3 DUKE Empirical Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.14.4 DUKE Empirical Embolism Protector Product Portfolio
6.14.5 DUKE Empirical Recent Developments/Updates
6.15 Emblok
6.15.1 Emblok Company Information
6.15.2 Emblok Description and Business Overview
6.15.3 Emblok Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Emblok Embolism Protector Product Portfolio
6.15.5 Emblok Recent Developments/Updates
6.16 Transverse Medical
6.16.1 Transverse Medical Company Information
6.16.2 Transverse Medical Description and Business Overview
6.16.3 Transverse Medical Embolism Protector Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Transverse Medical Embolism Protector Product Portfolio
6.16.5 Transverse Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Embolism Protector Industry Chain Analysis
7.2 Embolism Protector Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Embolism Protector Production Mode & Process Analysis
7.4 Embolism Protector Sales and Marketing
7.4.1 Embolism Protector Sales Channels
7.4.2 Embolism Protector Distributors
7.5 Embolism Protector Customer Analysis
8 Embolism Protector Market Dynamics
8.1 Embolism Protector Industry Trends
8.2 Embolism Protector Market Drivers
8.3 Embolism Protector Market Challenges
8.4 Embolism Protector Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Embolism Protector Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Embolism Protector Market Value by Protection Mechanism, (US$ Million) & (2024 VS 2031)
Table 3. Global Embolism Protector Market Value by Application (2024 VS 2031) & (US$ Million)
Table 4. Global Embolism Protector Market Competitive Situation by Manufacturers in 2024
Table 5. Global Embolism Protector Sales (K Units) of Key Manufacturers (2020-2025)
Table 6. Global Embolism Protector Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Embolism Protector Revenue (US$ Million) by Manufacturers (2020-2025)
Table 8. Global Embolism Protector Revenue Share by Manufacturers (2020-2025)
Table 9. Global Market Embolism Protector Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 10. Global Key Players of Embolism Protector, Industry Ranking, 2022 VS 2023 VS 2024
Table 11. Global Key Manufacturers of Embolism Protector, Manufacturing Sites & Headquarters
Table 12. Global Key Manufacturers of Embolism Protector, Product Type & Application
Table 13. Global Key Manufacturers of Embolism Protector, Date of Enter into This Industry
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Embolism Protector by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Embolism Protector as of 2024)
Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 17. Global Embolism Protector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 18. Global Embolism Protector Sales by Region (2020-2025) & (K Units)
Table 19. Global Embolism Protector Sales Market Share by Region (2020-2025)
Table 20. Global Embolism Protector Sales by Region (2026-2031) & (K Units)
Table 21. Global Embolism Protector Sales Market Share by Region (2026-2031)
Table 22. Global Embolism Protector Revenue by Region (2020-2025) & (US$ Million)
Table 23. Global Embolism Protector Revenue Market Share by Region (2020-2025)
Table 24. Global Embolism Protector Revenue by Region (2026-2031) & (US$ Million)
Table 25. Global Embolism Protector Revenue Market Share by Region (2026-2031)
Table 26. North America Embolism Protector Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 27. North America Embolism Protector Sales by Country (2020-2025) & (K Units)
Table 28. North America Embolism Protector Sales by Country (2026-2031) & (K Units)
Table 29. North America Embolism Protector Revenue by Country (2020-2025) & (US$ Million)
Table 30. North America Embolism Protector Revenue by Country (2026-2031) & (US$ Million)
Table 31. Europe Embolism Protector Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 32. Europe Embolism Protector Sales by Country (2020-2025) & (K Units)
Table 33. Europe Embolism Protector Sales by Country (2026-2031) & (K Units)
Table 34. Europe Embolism Protector Revenue by Country (2020-2025) & (US$ Million)
Table 35. Europe Embolism Protector Revenue by Country (2026-2031) & (US$ Million)
Table 36. Asia Pacific Embolism Protector Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 37. Asia Pacific Embolism Protector Sales by Region (2020-2025) & (K Units)
Table 38. Asia Pacific Embolism Protector Sales by Region (2026-2031) & (K Units)
Table 39. Asia Pacific Embolism Protector Revenue by Region (2020-2025) & (US$ Million)
Table 40. Asia Pacific Embolism Protector Revenue by Region (2026-2031) & (US$ Million)
Table 41. Latin America Embolism Protector Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 42. Latin America Embolism Protector Sales by Country (2020-2025) & (K Units)
Table 43. Latin America Embolism Protector Sales by Country (2026-2031) & (K Units)
Table 44. Latin America Embolism Protector Revenue by Country (2020-2025) & (US$ Million)
Table 45. Latin America Embolism Protector Revenue by Country (2026-2031) & (US$ Million)
Table 46. Middle East and Africa Embolism Protector Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 47. Middle East and Africa Embolism Protector Sales by Country (2020-2025) & (K Units)
Table 48. Middle East and Africa Embolism Protector Sales by Country (2026-2031) & (K Units)
Table 49. Middle East and Africa Embolism Protector Revenue by Country (2020-2025) & (US$ Million)
Table 50. Middle East and Africa Embolism Protector Revenue by Country (2026-2031) & (US$ Million)
Table 51. Global Embolism Protector Sales (K Units) by Type (2020-2025)
Table 52. Global Embolism Protector Sales (K Units) by Type (2026-2031)
Table 53. Global Embolism Protector Sales Market Share by Type (2020-2025)
Table 54. Global Embolism Protector Sales Market Share by Type (2026-2031)
Table 55. Global Embolism Protector Revenue (US$ Million) by Type (2020-2025)
Table 56. Global Embolism Protector Revenue (US$ Million) by Type (2026-2031)
Table 57. Global Embolism Protector Revenue Market Share by Type (2020-2025)
Table 58. Global Embolism Protector Revenue Market Share by Type (2026-2031)
Table 59. Global Embolism Protector Price (US$/Unit) by Type (2020-2025)
Table 60. Global Embolism Protector Price (US$/Unit) by Type (2026-2031)
Table 61. Global Embolism Protector Sales (K Units) by Application (2020-2025)
Table 62. Global Embolism Protector Sales (K Units) by Application (2026-2031)
Table 63. Global Embolism Protector Sales Market Share by Application (2020-2025)
Table 64. Global Embolism Protector Sales Market Share by Application (2026-2031)
Table 65. Global Embolism Protector Revenue (US$ Million) by Application (2020-2025)
Table 66. Global Embolism Protector Revenue (US$ Million) by Application (2026-2031)
Table 67. Global Embolism Protector Revenue Market Share by Application (2020-2025)
Table 68. Global Embolism Protector Revenue Market Share by Application (2026-2031)
Table 69. Global Embolism Protector Price (US$/Unit) by Application (2020-2025)
Table 70. Global Embolism Protector Price (US$/Unit) by Application (2026-2031)
Table 71. Int Medical Company Information
Table 72. Int Medical Description and Business Overview
Table 73. Int Medical Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 74. Int Medical Embolism Protector Product
Table 75. Int Medical Recent Developments/Updates
Table 76. Microport Company Information
Table 77. Microport Description and Business Overview
Table 78. Microport Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 79. Microport Embolism Protector Product
Table 80. Microport Recent Developments/Updates
Table 81. Skynor Medical Company Information
Table 82. Skynor Medical Description and Business Overview
Table 83. Skynor Medical Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 84. Skynor Medical Embolism Protector Product
Table 85. Skynor Medical Recent Developments/Updates
Table 86. Venus Medtech (Hangzhou) Inc. Company Information
Table 87. Venus Medtech (Hangzhou) Inc. Description and Business Overview
Table 88. Venus Medtech (Hangzhou) Inc. Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 89. Venus Medtech (Hangzhou) Inc. Embolism Protector Product
Table 90. Venus Medtech (Hangzhou) Inc. Recent Developments/Updates
Table 91. Medtronic Company Information
Table 92. Medtronic Description and Business Overview
Table 93. Medtronic Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 94. Medtronic Embolism Protector Product
Table 95. Medtronic Recent Developments/Updates
Table 96. LEPU MEDICAL Company Information
Table 97. LEPU MEDICAL Description and Business Overview
Table 98. LEPU MEDICAL Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. LEPU MEDICAL Embolism Protector Product
Table 100. LEPU MEDICAL Recent Developments/Updates
Table 101. Cordis Company Information
Table 102. Cordis Description and Business Overview
Table 103. Cordis Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Cordis Embolism Protector Product
Table 105. Cordis Recent Developments/Updates
Table 106. Filterlex Company Information
Table 107. Filterlex Description and Business Overview
Table 108. Filterlex Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Filterlex Embolism Protector Product
Table 110. Filterlex Recent Developments/Updates
Table 111. invamed Company Information
Table 112. invamed Description and Business Overview
Table 113. invamed Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. invamed Embolism Protector Product
Table 115. invamed Recent Developments/Updates
Table 116. Shanghai HeartCare Medical Technology Corporation Limited Company Information
Table 117. Shanghai HeartCare Medical Technology Corporation Limited Description and Business Overview
Table 118. Shanghai HeartCare Medical Technology Corporation Limited Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Shanghai HeartCare Medical Technology Corporation Limited Embolism Protector Product
Table 120. Shanghai HeartCare Medical Technology Corporation Limited Recent Developments/Updates
Table 121. Boston Scientific Company Information
Table 122. Boston Scientific Description and Business Overview
Table 123. Boston Scientific Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. Boston Scientific Embolism Protector Product
Table 125. Boston Scientific Recent Developments/Updates
Table 126. Parite Medikal Company Information
Table 127. Parite Medikal Description and Business Overview
Table 128. Parite Medikal Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Parite Medikal Embolism Protector Product
Table 130. Parite Medikal Recent Developments/Updates
Table 131. Abbott Company Information
Table 132. Abbott Description and Business Overview
Table 133. Abbott Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Abbott Embolism Protector Product
Table 135. Abbott Recent Developments/Updates
Table 136. DUKE Empirical Company Information
Table 137. DUKE Empirical Description and Business Overview
Table 138. DUKE Empirical Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. DUKE Empirical Embolism Protector Product
Table 140. DUKE Empirical Recent Developments/Updates
Table 141. Emblok Company Information
Table 142. Emblok Description and Business Overview
Table 143. Emblok Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Emblok Embolism Protector Product
Table 145. Emblok Recent Developments/Updates
Table 146. Transverse Medical Company Information
Table 147. Transverse Medical Description and Business Overview
Table 148. Transverse Medical Embolism Protector Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. Transverse Medical Embolism Protector Product
Table 150. Transverse Medical Recent Developments/Updates
Table 151. Key Raw Materials Lists
Table 152. Raw Materials Key Suppliers Lists
Table 153. Embolism Protector Distributors List
Table 154. Embolism Protector Customers List
Table 155. Embolism Protector Market Trends
Table 156. Embolism Protector Market Drivers
Table 157. Embolism Protector Market Challenges
Table 158. Embolism Protector Market Restraints
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
Table 162. Authors List of This Report


List of Figures
Figure 1. Product Picture of Embolism Protector
Figure 2. Global Embolism Protector Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Embolism Protector Market Share by Type: 2024 & 2031
Figure 4. Carotid Embolism Protection Device Product Picture
Figure 5. Peripheral Vascular Embolism Protector Product Picture
Figure 6. Coronary Embolism Protector Product Picture
Figure 7. Global Embolism Protector Market Value by Protection Mechanism, (US$ Million) & (2020-2031)
Figure 8. Global Embolism Protector Market Share by Protection Mechanism: 2024 VS 2031
Figure 9. Filter-Type Embolism Protector Product Picture
Figure 10. Balloon-Occlusion Embolism Protector Product Picture
Figure 11. Flow-Reversal Embolism Protector Product Picture
Figure 12. Global Embolism Protector Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Embolism Protector Market Share by Application: 2024 & 2031
Figure 14. Cardiovascular Intervention Centers
Figure 15. General Hospitals
Figure 16. Specialized Vascular Clinics
Figure 17. Global Embolism Protector Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Embolism Protector Market Size (2020-2031) & (US$ Million)
Figure 19. Global Embolism Protector Sales (2020-2031) & (K Units)
Figure 20. Global Embolism Protector Average Price (US$/Unit) & (2020-2031)
Figure 21. Embolism Protector Report Years Considered
Figure 22. Embolism Protector Sales Share by Manufacturers in 2024
Figure 23. Global Embolism Protector Revenue Share by Manufacturers in 2024
Figure 24. Global 5 and 10 Largest Embolism Protector Players: Market Share by Revenue in Embolism Protector in 2024
Figure 25. Embolism Protector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 26. Global Embolism Protector Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 27. North America Embolism Protector Sales Market Share by Country (2020-2031)
Figure 28. North America Embolism Protector Revenue Market Share by Country (2020-2031)
Figure 29. United States Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Canada Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Europe Embolism Protector Sales Market Share by Country (2020-2031)
Figure 32. Europe Embolism Protector Revenue Market Share by Country (2020-2031)
Figure 33. Germany Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Russia Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Embolism Protector Sales Market Share by Region (2020-2031)
Figure 39. Asia Pacific Embolism Protector Revenue Market Share by Region (2020-2031)
Figure 40. China Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Japan Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. South Korea Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. India Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Australia Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. China Taiwan Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Southeast Asia Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Latin America Embolism Protector Sales Market Share by Country (2020-2031)
Figure 48. Latin America Embolism Protector Revenue Market Share by Country (2020-2031)
Figure 49. Mexico Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Brazil Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Argentina Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Colombia Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Embolism Protector Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Embolism Protector Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Embolism Protector Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Embolism Protector by Type (2020-2031)
Figure 59. Global Revenue Market Share of Embolism Protector by Type (2020-2031)
Figure 60. Global Embolism Protector Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Embolism Protector by Application (2020-2031)
Figure 62. Global Revenue Market Share of Embolism Protector by Application (2020-2031)
Figure 63. Global Embolism Protector Price (US$/Unit) by Application (2020-2031)
Figure 64. Embolism Protector Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

Our Clients